Prevalence and factors associated with uptake of pre-exposure prophylaxis amongst women vulnerable to HIV who received HIV antibodies in Antibody Mediated Prevention HVTN703/HPTN081 trial in Harare, Zimbabwe: a cross-sectional study.

Autor: Siziba B; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Mgodi NM; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Ngara B; University of Zimbabwe College of Health Sciences, Harare, Zimbabwe., Chawana TD; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Chitukuta M; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Mukwekwerere PG; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Bhondai-Mhuri M; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Chirenje ZM; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.; University of California San Francisco, San Francisco, California, USA., Mhlanga FGS; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.

Publikováno v: BMJ public health [BMJ Public Health] 2024 Jul; Vol. 2 (1). Date of Electronic Publication: 2024 Apr 16.